T. Rusch

Eltanexor Effectively Reduces Viability of Glioblastoma and Glioblastoma Stem-Like Cells at Nano-Molar Concentrations and Sensitizes to Radiotherapy and Temozolomide

C. Nimsky, H. Raifer, A. Neubauer, 2022, Biomedicines.

Immunotherapy as an Option for Cancer Treatment

J. Werner, A. Bazhin, J. Bayry, 2017, Archivum Immunologiae et Therapiae Experimentalis.

Enhanced lysis by bispecific oncolytic measles viruses simultaneously using HER2/neu or EpCAM as target receptors

A. Plückthun, K. Cichutek, C. Buchholz, 2016, Molecular therapy oncolytics.